about
Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertensionBidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromePotential role of thymosin Beta 4 in liver fibrosisThe wound healing, chronic fibrosis, and cancer progression triadSpaceflight Activates Lipotoxic Pathways in Mouse LiverThe tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancerCurcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cellsGlobal gene expression profiling in PAI-1 knockout murine heart and kidney: molecular basis of cardiac-selective fibrosisDating Endometriotic Ovarian Cysts Based on the Content of Cyst Fluid and its Potential Clinical ImplicationsGlibenclamide induces collagen IV catabolism in high glucose-stimulated mesangial cells.Recombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice.Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetesHigh molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodelingCellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosisAn anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells.Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments.Smoking-related cotinine levels and host responses in chronic periodontitis.Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation.The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary.Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potentialLow-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner.Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1.TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair.Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices.Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosisDifferential regenerative capacity of neonatal mouse hearts after cryoinjury.Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblastsA plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes5Z-7-Oxozeanol Inhibits the Effects of TGFβ1 on Human Gingival FibroblastsAbrogation of plasminogen activator inhibitor-1-vitronectin interaction ameliorates acute kidney injury in murine endotoxemia.Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.Amniotic Membrane Modifies the Genetic Program Induced by TGFß, Stimulating Keratinocyte Proliferation and Migration in Chronic Wounds.Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factorCYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating AktInhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.Keloids and Hypertrophic Scars: A Spectrum of Clinical Challenges.ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors.Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.
P2860
Q26744048-89C4C2C2-37FC-4CBF-99E5-D6A5ABFEDC10Q26765455-78F7B456-01C8-4D71-B033-0AF9209DB48DQ27003833-44E53D97-B3EE-45CC-A358-9B9F27E92CF4Q27014616-AE489DFC-5420-4920-B44B-CC94B3C2798BQ27315146-F4B3EC03-FCF3-401E-9184-4E2C4E758759Q28261714-B38FA234-F504-4C99-9666-9ADC3694DD8CQ28489058-3F80A80E-F56A-45BB-99C5-7912EFEC9473Q28533371-8B5BB6E5-3381-4FAB-A63F-8E7B19E0C717Q28607792-312AD53F-B765-40F5-86AC-673620BCD235Q29347062-773B5DBA-02A2-4F89-A498-61C091E842B8Q30301012-4903132A-40E0-4D30-8852-454113242FA8Q31132310-04EB2C6D-6041-4D7C-82C8-FAF8715C53F3Q31161236-4EA74BCA-2369-4A2B-8EDB-DBB32D666FF1Q33569405-AF4172AB-2642-45E9-9227-494ABAD3079FQ33618778-F33CDE25-A193-4EF3-B661-E210808E73E0Q33645678-F59ED7FC-0501-4049-A495-053CECAA5EB8Q33671473-0317C212-707E-4997-B83F-22ABF3E22DD6Q34295008-605973FA-64EB-4B77-9CE7-357FAB3727C3Q34377973-6FB89823-2CE7-4C17-B0AA-DF00DE37EA80Q34393020-EA5F1ABC-DA84-4062-8857-3B4FA3190ACDQ34530252-ABB43C51-59A7-4C34-A116-378BD3A6797BQ34540845-C74B86D2-0E79-473D-8E91-25C7559D1F68Q34772461-E5654068-05CF-4E09-817D-F2D6A8291AB3Q34962663-10CFAE1E-19EF-4B01-976D-D69B0356C5FBQ34976113-0DAEF105-5913-480E-8148-6A08748DA879Q35086389-5C99C0B0-FB59-4EFC-AF83-25B402D9E1B4Q35118442-8E75F9B6-0ACE-4C2F-BFA4-3568F14130AFQ35180538-5EA6D7D6-D664-4AC9-A0F9-FD65C9F1C811Q35185276-73B1061A-8867-4DF6-ACB0-9998C2DD5DD0Q35558533-F5A082C3-F94D-4C21-AEF5-8D80A9A4468BQ35584207-50BC4BD9-3DA8-4C1E-B854-D59224373008Q35678791-862EE1BA-0FEF-4340-8D41-F4642545ED70Q35748590-41861A5D-E921-4AE0-ACCD-CB323F7EB86EQ35764595-1C07E0A5-F115-4874-8FB5-A2A5158EC16CQ35874554-20E92E4D-8E8D-435A-9389-5742B93B6D72Q35916665-5504D00C-D46E-486D-891C-2CECAE957272Q35918076-E457B7E6-7E78-4734-8703-63C02FC09BFEQ35928377-92C99E4C-8482-47E7-8749-1235826F33BAQ35987913-6F684F5D-E4FB-409A-950F-82B7B89E0F2FQ35994934-51917D9F-1EA8-49B5-9A76-F5D4FE5A408A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PAI-1 in tissue fibrosis.
@en
PAI-1 in tissue fibrosis.
@nl
type
label
PAI-1 in tissue fibrosis.
@en
PAI-1 in tissue fibrosis.
@nl
prefLabel
PAI-1 in tissue fibrosis.
@en
PAI-1 in tissue fibrosis.
@nl
P2860
P356
P1476
PAI-1 in tissue fibrosis.
@en
P2093
Asish K Ghosh
Douglas E Vaughan
P2860
P304
P356
10.1002/JCP.22783
P577
2012-02-01T00:00:00Z